1. Repository of OAI
Ελληνικά   English  

Browsing by Author Athyros, V. G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 5 to 24 of 50 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysisChimonas, T.; Karagiannis, A.; Athyros, V. G.; Achimastos, A.; Elisaf, M. S.; Panagiotakos, D. B.24-Nov-2015-
Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndromeChimonas, T.; Athyros, V. G.; Ganotakis, E.; Nicolaou, V.; Panagiotakos, D. B.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) StudyDiamantopoulos, E. J.; Athyros, V. G.; Yfanti, G. K.; Migdalis, E. N.; Elisaf, M. S.; Vardas, P. E.; Manolis, A. S.; Karamitsos, D. T.; Ganotakis, E. S.; Hatseras, D.24-Nov-2015-
Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjectsMilionis, H. J.; Kostapanos, M. S.; Liberopoulos, E. N.; Goudevenos, J.; Athyros, V. G.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Dyslipidaemia, hypercoagulability and the metabolic syndromeKakafika, A. I.; Liberopoulos, E. N.; Karagiannis, A.; Athyros, V. G.; Mikhailidis, D. P.24-Nov-2015-
Effect of apolipoprotein E polymorphism on serum uric acid levels in healthy subjectsLiberopoulos, E. N.; Miltiadous, G. A.; Athyros, V. G.; Ganotakis, M.; Cariolou, M.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) StudyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Symeonidis, A. N.; Mercouris, B. R.; Pehlivanidis, A.; Bouloukos, V. I.; Elisaf, M. S.24-Nov-2015-
The effect of cholesterol-lowering treatment on renal functionLiberopoulos, E. N.; Mikhailidis, D. P.; Athyros, V. G.; Elisaf, M. S.24-Nov-2015-
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised studyAthyros, V. G.; Mikhailidis, D. P.; Didangelos, T. P.; Giouleme, O. I.; Liberopoulos, E. N.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Burroughs, A. K.; Elisaf, M. S.24-Nov-2015-
The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndromeFilippatos, T. D.; Gazi, I. F.; Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Tselepis, A. D.; Kiortsis, D. N.24-Nov-2015-
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) StudyAthyros, V. G.; Mikhailidis, D. P.; Liberopoulos, E. N.; Kakafika, A. I.; Karagiannis, A.; Papageorgiou, A. A.; Tziomalos, K.; Ganotakis, E. S.; Elisaf, M. S.24-Nov-2015-
Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart diseaseAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Bouloukos, V. I.; Pehlivanidis, A. N.; Symeonidis, A. N.; Elisaf, M. S.24-Nov-2015-
Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE studyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Bouloukos, V. I.; Pehlivanidis, A. N.; Symeonidis, A. N.; Kakafika, A. I.; Daskalopoulou, S. S.; Elisaf, M. S.24-Nov-2015-
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) studyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Symeonidis, A. N.; Pehlivanidis, A. N.; Bouloukos, V. I.; Elisaf, M. S.24-Nov-2015-
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) studyAthyros, V. G.; Elisaf, M. S.; Papageorgiou, A. A.; Symeonidis, A. N.; Pehlivanidis, A. N.; Bouloukos, V. I.; Milionis, H. J.; Mikhailidis, D. P.24-Nov-2015-
Effects of combination of orlistat and micronised fenofibrate on lipid profile in overweight and obese patients with metabolic syndromeFilippatos, T. D.; Kiortsis, D. N.; Tselepis, A. D.; Athyros, V. G.; Elisaf, M. S.24-Nov-2015-
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemiaMilionis, H. J.; Kakafika, A. I.; Tsouli, S. G.; Athyros, V. G.; Bairaktari, E. T.; Seferiadis, K. I.; Elisaf, M. S.24-Nov-2015-
Effects of various fibrates on serum alkaline phosphatase activityGanotakis, E.; Tsimihodimos, V.; Bairaktari, E.; Rizos, E.; Athyros, V. G.; Seferiades, C.; Elisaf, M. S.24-Nov-2015-
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?Tsouli, S. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Athyros, V. G.; Elisaf, M. S.24-Nov-2015-
European Panel on Low Density Lipoprotein (LDL) Subclasses: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL SubclassesMikhailidis, D. P.; Elisaf, M.; Rizzo, M.; Berneis, K.; Griffin, B.; Zambon, A.; Athyros, V. G.; de Graaf, J.; Marz, W.; Parhofer, K. G.; Rini, G. B.; Spinas, G. A.; Tomkin, G. H.; Tselepis, A. D.; Wierzbicki, A. S.; Winkler, K.; Florentin, M.; Liberopoulos, E.24-Nov-2015-
Showing results 5 to 24 of 50 < previous   next >